Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
48
ASND Quote, Financials, Valuation and Earnings
Last price:
$166.13
Seasonality move
:
-9.72%
Day range:
$163.93 - $168.97
52-week range:
$111.09 - $169.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
24.32x
P/B ratio:
--
Volume:
393K
Avg. volume:
552K
1-year change:
11.96%
Market cap:
$9.9B
Revenue:
$393.6M
EPS (TTM):
-$7.13
Earnings Data
Next earnings date for ASND
May 02
2025
Most recent earnings per share
-$0.68
Beat by $0.28
(Feb 12/2025)
Consensus Estimate
-$0.96
(Feb 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ASND Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/02/2025 | Q1 | $102.3M | -- | -- | -$1.64 | -- |
| 02/12/2025 | Q4 | $123.2M | $185.4M | -$0.68 | -$0.96 | $0.28 |
| 11/14/2024 | Q3 | $76.5M | $63.6M | -$1.89 | -$1.57 | -$0.32 |
| 09/03/2024 | Q2 | $94.2M | $38.8M | -$2.06 | -$1.40 | -$0.65 |
| 05/02/2024 | Q1 | $85.6M | $104.2M | -$2.50 | -$1.52 | -$0.98 |
| 02/07/2024 | Q4 | $92.1M | $148.3M | -$1.66 | -$1.90 | $0.24 |
| 11/07/2023 | Q3 | -- | -- | -$3.14 | -$2.37 | -$0.76 |
| 09/05/2023 | Q2 | -- | -- | -$2.36 | -$2.80 | $0.45 |
| 04/27/2023 | Q1 | -- | -- | -$2.13 | -$2.89 | $0.77 |
| 02/16/2023 | Q4 | -- | -- | -$3.78 | -$2.77 | -$1.02 |
| 11/02/2022 | Q3 | -- | -- | -$3.05 | -$2.52 | -$0.53 |
| 08/10/2022 | Q2 | -- | -- | -$1.56 | -$2.28 | $0.73 |
| 05/11/2022 | Q1 | -- | -- | -$2.48 | -$2.15 | -$0.33 |
| 03/02/2022 | Q4 | -- | -- | -$2.14 | -$2.59 | $0.46 |
| 11/10/2021 | Q3 | -- | -- | -- | -$2.66 | -- |
| 08/25/2021 | Q2 | -- | -- | -$3.01 | -$2.64 | -$0.37 |
| 05/27/2021 | Q1 | -- | -- | -$1.41 | -$2.27 | $0.86 |
| 03/10/2021 | Q4 | -- | -- | -$3.15 | -$1.88 | -$1.27 |
| 11/11/2020 | Q3 | -- | -- | -$2.70 | -$1.87 | -$0.83 |
| 08/27/2020 | Q2 | -- | -- | -$2.17 | -$1.60 | -$0.57 |
| 05/19/2020 | Q1 | -- | -- | -$1.46 | -$1.40 | -$0.05 |
| 12/31/2019 | Q4 | -- | -- | -$1.88 | -$1.32 | -$0.56 |
| 11/18/2019 | Q3 | -- | -- | -$0.59 | -$1.28 | $0.69 |
| 08/28/2019 | Q2 | -- | -- | -- | -$1.33 | -- |
| 04/03/2019 | Q1 | -- | -- | -- | -$1.14 | -- |
| 12/31/2018 | Q4 | -- | -- | -- | -$1.13 | -- |
| 11/28/2018 | Q3 | -- | -- | -- | -$1.20 | -- |
| 08/29/2018 | Q2 | -- | -- | -- | -$0.99 | -- |
| 05/30/2018 | Q1 | -- | -- | -- | -- | -- |
| 03/28/2018 | Q4 | -- | -- | -- | -- | -- |
| 11/16/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/18/2017 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/30/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/31/2016 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -- | -- | -- |
Ascendis Pharma AS Earnings Questions
-
How Much did Ascendis Pharma AS Generate in Revenue Last Quarter?
Ascendis Pharma AS reported $185.4M worth of top line sales in its most recent quarter.
-
Did Ascendis Pharma AS Beat Earnings Last Quarter?
Ascendis Pharma AS announced earnings per share of -$0.68 which represents a beat of analyst forecast a -$0.96 per share.
-
Is Ascendis Pharma AS Profitable?
Ascendis Pharma AS reported $170.4M that represents $2.85 per share over the last quarter.
-
What is the Analyst Consensus for Ascendis Pharma AS EPS Next Year?
Ascendis Pharma AS's earnings are forecast to decrease from -$7.07 per share to -$6.78 per share next year representing a decrease of -49.44%.
-
When is Ascendis Pharma AS's Earnings Date?
Ascendis Pharma AS's next earnings date is May 2, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
